Wnt family member 10B mRNA 3' untranslated region (WNT10B mRNA 3'UTR) (WNT10B mRNA 3'UTR)

The Wnt family member 10B (WNT10B) mRNA 3' untranslated region (3'UTR) is a critical regulatory segment of the WNT10B transcript that governs protein expression through post-transcriptional mechanisms (PubMed: 21602466). This region contains multiple microRNA response elements (MREs) that serve as binding sites for various microRNAs, such as miR-148a, miR-329, and miR-29, which typically act to destabilize the mRNA or inhibit its translation (PubMed: 24561048, PubMed: 23871475). WNT10B itself is a key activator of the canonical Wnt/beta-catenin signaling pathway, playing a pivotal role in promoting osteoblast differentiation and inhibiting adipocyte formation (PubMed: 15282614). Consequently, the WNT10B mRNA 3'UTR is a significant therapeutic target for conditions characterized by dysregulated Wnt signaling, including obesity, osteoporosis, and certain malignancies like breast cancer (PubMed: 25613315). Therapeutic strategies focusing on this region include the use of microRNA mimics to downregulate WNT10B in oncogenic contexts or antisense oligonucleotides (ASOs) to block inhibitory microRNA binding, thereby upregulating the protein in regenerative medicine. While promising, challenges remain regarding the precise delivery of these RNA-targeted agents to specific tissues and the potential for off-target interactions within the complex cellular transcriptome.

Other names

WNT10B 3'UTRWingless-type MMTV integration site family member 10B 3' untranslated regionWNT12 mRNA 3'UTR

Modulation of mRNA stability and translation through competitive or complementary binding to regulatory sequences, such as microRNA response elements (MREs), within the 3' untranslated region (PubMed: 21602466).